The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Axcella Health Inc | COM | 05454B105 | 5,805,480 | 18,142,125 | SH | DFND | 2,3 | 0 | 18,142,125 | 0 | ||
| Axcella Health Inc | COM | 05454B105 | 3,555,015 | 11,109,420 | SH | DFND | 3 | 0 | 11,109,420 | 0 | ||
| Codiak Biosciences Inc | COM | 192010106 | 1,191,328 | 3,054,687 | SH | DFND | 1,3 | 0 | 3,054,687 | 0 | ||
| Codiak Biosciences Inc | COM | 192010106 | 189,520 | 485,949 | SH | DFND | 3 | 0 | 485,949 | 0 | ||
| Denali Therapeutics Inc | COM | 24823R105 | 72,861,310 | 2,619,968 | SH | DFND | 1,3 | 0 | 2,619,968 | 0 | ||
| Evelo Biosciences Inc | COM | 299734103 | 16,361,890 | 10,162,664 | SH | DFND | 2,3 | 0 | 10,162,664 | 0 | ||
| Evelo Biosciences Inc | COM | 299734103 | 16,430,504 | 10,205,282 | SH | DFND | 1,3 | 0 | 10,205,282 | 0 | ||
| Evelo Biosciences Inc | COM | 299734103 | 48,395,606 | 30,059,382 | SH | DFND | 3 | 0 | 30,059,382 | 0 | ||
| Foghorn Therapeutics Inc | COM | 344174107 | 59,531,002 | 9,330,878 | SH | DFND | 1,3 | 0 | 9,330,878 | 0 | ||
| Foghorn Therapeutics Inc | COM | 344174107 | 21,329,884 | 3,343,242 | SH | DFND | 3 | 0 | 3,343,242 | 0 | ||
| Moderna Inc | COM | 60770K107 | 2,314,011,949 | 12,882,819 | SH | DFND | 2,3 | 0 | 12,882,819 | 0 | ||
| Moderna Inc | COM | 60770K107 | 704,829 | 3,924 | SH | DFND | 3 | 0 | 3,924 | 0 | ||
| Omega Therapeutics Inc | COM | 68217N105 | 79,138,418 | 6,984,856 | SH | DFND | 1,3 | 0 | 6,984,856 | 0 | ||
| Omega Therapeutics Inc | COM | 68217N105 | 214,334,288 | 18,917,413 | SH | DFND | 3 | 0 | 18,917,413 | 0 | ||
| Rubius Therapeutics Inc | COM | 78116T103 | 4,118,079 | 24,223,995 | SH | DFND | 2,3 | 0 | 24,223,995 | 0 | ||
| Rubius Therapeutics Inc | COM | 78116T103 | 1,980,300 | 11,648,828 | SH | DFND | 1,3 | 0 | 11,648,828 | 0 | ||
| Rubius Therapeutics Inc | COM | 78116T103 | 447,730 | 2,633,703 | SH | DFND | 3 | 0 | 2,633,703 | 0 | ||
| Sana Biotechnology Inc | COM | 799566104 | 51,636,651 | 13,072,570 | SH | DFND | 1,3 | 0 | 13,072,570 | 0 | ||
| Sana Biotechnology Inc | COM | 799566104 | 83,607,470 | 21,166,448 | SH | DFND | 3 | 0 | 21,166,448 | 0 | ||
| Seres Therapeutics Inc | COM | 81750R102 | 47,336,105 | 8,452,876 | SH | DFND | 2,3 | 0 | 8,452,876 | 0 | ||
| Seres Therapeutics Inc | COM | 81750R102 | 82,119,347 | 14,664,169 | SH | DFND | 3 | 0 | 14,664,169 | 0 | ||
| Sigilon Therapeutics Inc | COM | 82657L107 | 3,111,111 | 8,888,888 | SH | DFND | 1,3 | 0 | 8,888,888 | 0 | ||
| Sigilon Therapeutics Inc | COM | 82657L107 | 518,518 | 1,481,481 | SH | DFND | 3 | 0 | 1,481,481 | 0 | ||
| Syros Pharmaceuticals Inc | COM | 87184Q206 | 1,054,914 | 293,848 | SH | DFND | 2,3 | 0 | 293,848 | 0 | ||
| Syros Pharmaceuticals Inc | COM | 87184Q206 | 2,513,000 | 700,000 | SH | DFND | 3 | 0 | 700,000 | 0 | ||